GlassScriptPhysician profile
Edward G Mintz
NPI 1629030283
$2,224.69
in general payments reported to CMS, 2019-2025
22 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $64.86 · 2021: $285 · 2022: $483 · 2023: $493 · 2024: $81.01 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $879.75 | 2019-2025 | Clareon, Rocklatan, Total30 |
| Novartis Pharmaceuticals Corporation | $372.66 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $176.22 | 2019-2023 | Cequa |
| Glaukos Corporation | $125.05 | 2019-2025 | Idosetr |
| Rayner Intraocular Lenses Limited | $76.86 | 2023-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Aerie Pharmaceuticals, INC. | $75.58 | 2019-2021 | |
| Abbvie INC. | $73.67 | 2023-2025 | |
| Allergan, INC. | $59.31 | 2019-2022 | |
| Amgen INC. | $54.24 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $43.18 | 2019-2023 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $36.80 | 2023-2025 | Xiidra, Miebo |
| Omeros Corporation | $34.74 | 2019 | |
| Horizon Therapeutics Plc | $32.15 | 2021-2022 | |
| Sight Sciences, INC. | $32.11 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $30.57 | 2023 | Clarus |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $24.64 | 2022 | |
| Dompe US, INC. | $20.78 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.52 | 2019 | |
| Thea Pharma INC. | $18.14 | 2023 | |
| New World Medical,INC. | $15.56 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Kala Pharmaceuticals, INC. | $13.88 | 2021 | |
| Biotissue Holdings INC. | $8.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.